- Home
- STIM vs ACB Comparison
STIM vs ACB Comparison
Compare STIM & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- ACB
- Stock Information
- Founded
- STIM 2003
- ACB 2013
- Country
- STIM United States
- ACB Canada
- Employees
- STIM N/A
- ACB N/A
- Industry
- STIM Medical/Dental Instruments
- ACB Pharmaceuticals and Biotechnology
- Sector
- STIM Health Care
- ACB Health Care
- Exchange
- STIM Nasdaq
- ACB Nasdaq
- Market Cap
- STIM 232.3M
- ACB 234.9M
- IPO Year
- STIM 2018
- ACB N/A
- Fundamental
- Price
- STIM $3.76
- ACB $4.44
- Analyst Decision
- STIM Buy
- ACB Hold
- Analyst Count
- STIM 4
- ACB 1
- Target Price
- STIM $6.00
- ACB N/A
- AVG Volume (30 Days)
- STIM 1.1M
- ACB 1.0M
- Earning Date
- STIM 05-06-2025
- ACB 02-05-2025
- Dividend Yield
- STIM N/A
- ACB N/A
- EPS Growth
- STIM N/A
- ACB N/A
- EPS
- STIM N/A
- ACB 0.07
- Revenue
- STIM $74,890,000.00
- ACB $222,964,332.00
- Revenue This Year
- STIM $102.36
- ACB $28.17
- Revenue Next Year
- STIM $9.83
- ACB $12.95
- P/E Ratio
- STIM N/A
- ACB $69.63
- Revenue Growth
- STIM 4.96
- ACB 20.72
- 52 Week Low
- STIM $0.52
- ACB $3.42
- 52 Week High
- STIM $5.92
- ACB $9.35
- Technical
- Relative Strength Index (RSI)
- STIM 45.71
- ACB 51.20
- Support Level
- STIM $3.46
- ACB $4.16
- Resistance Level
- STIM $4.14
- ACB $4.50
- Average True Range (ATR)
- STIM 0.40
- ACB 0.28
- MACD
- STIM -0.00
- ACB 0.04
- Stochastic Oscillator
- STIM 56.52
- ACB 89.61
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.